Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0200
-0.0013 (-6.10%)
At close: Jun 17, 2026
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $836.9 thousand as of June 17, 2026. Its market cap has decreased by -88.73% in one year.
Market Cap
836.90K
Enterprise Value
-1.18M
Revenue
52.63M
Ranking
n/a
PE Ratio
0.10
Stock Price
$0.02
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 836.90K, a decrease of -99.43%. That is a compound annual growth rate of -79.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 836.90K | -53.49% |
| Dec 31, 2025 | 1.80M | -89.71% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyra Therapeutics | 1.22M |
| Burzynski Research Institute | 1.12M |
| Evofem Biosciences | 927.71K |
| Avenue Therapeutics | 889.64K |
| Windtree Therapeutics | 809.78K |
| Halberd | 784.67K |
| Protagenic Therapeutics | 742.19K |
| SQZ Biotechnologies Company | 707.79K |